Actinium Pharma (ATNM) – Litigation
-
Actinium Pharma (ATNM) Strengthens Patent Portfolio with International IP Covering the Composition and Methods of Administration of Iomab-B Antibody Radiation Conjugate in the EU and Japan
-
Actinium Pharma (ATNM) Announces Notice of Allowance for U.S. Patent Related to Actimab-A, Actimab-M and Technology Platform
-
-
Back to ATNM Stock Lookup